A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)
A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
A malignant epithelial tumor with a glandular organization.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
Tumors or cancer of the UTERINE CERVIX.
Tumors or cancer of the LUNG.
Plutonium. A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, atomic number 94, and atomic weight 242. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
Diseases of the lacrimal apparatus.
Tumors or cancer of the gallbladder.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Retrograde flow of duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the STOMACH.
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Surgical removal of the pancreas. (Dorland, 28th ed)
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
A family of small, non-enveloped DNA viruses infecting birds and most mammals, especially humans. They are grouped into multiple genera, but the viruses are highly host-species specific and tissue-restricted. They are commonly divided into hundreds of papillomavirus "types", each with specific gene function and gene control regions, despite sequence homology. Human papillomaviruses are found in the genera ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; GAMMAPAPILLOMAVIRUS; and MUPAPILLOMAVIRUS.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
Tumors or cancer of the LIVER.
The performance of dissections with the aid of a microscope.
An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.
A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.
A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF-related peptides including TRANSFORMING GROWTH FACTOR ALPHA; AMPHIREGULIN; and HEPARIN-BINDING EGF-LIKE GROWTH FACTOR. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
The proportion of patients with a particular disease during a given year per given unit of population.
Biochemical identification of mutational changes in a nucleotide sequence.

Human papillomavirus DNA in adenosquamous carcinoma of the lung. (1/236)

AIM: To investigate the presence of human papillomavirus (HPV) DNA in adenosquamous carcinoma of the lung--which is relatively common in Okinawa but not in mainland Japan--and examine its histological features. METHODS: Of 207 cases where primary lung cancers were surgically removed between January 1995 and June 1997 in Okinawa, 23 were adenosquamous carcinoma. HPV was detected by non-isotopic in situ hybridisation (NISH) and polymerase chain reaction (PCR) amplification with primers specific for E6 and E7 regions of the HPV genome. PCR products were analysed by Southern blotting. Immunohistochemical determination of high molecular weight cytokeratin (HMC) and involucrin was also carried out. RESULTS: 18 cases were positive for HPV DNA by PCR and NISH. HPV types 6, 11, 16, and 18 were found. Seven cases were dual positive for different types of HPV. Using NISH, HPV was also found in the squamous cell components and in neighbouring enlarged adenocarcinoma cells. The HMC and involucrin were demonstrated immunohistochemically in the same areas. CONCLUSIONS: HPV DNA was found in a high proportion (78.3%) of adenosquamous carcinomas in Okinawa, a region where HPV has previously been shown to be prevalent in squamous cell carcinoma of the lung. The adenocarcinoma cells adjacent to the squamous cell carcinoma component were enlarged and positive for HPV, HMC, and involucrin. This is thought to indicate the transition from adenocarcinoma to squamous cell carcinoma.  (+info)

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. (2/236)

PURPOSE: In 1986, a protocol comparing primary radiation therapy (RT) plus hydroxyurea (HU) to irradiation plus fluorouracil (5-FU) and cisplatin (CF) was activated by the Gynecologic Oncology Group (GOG) for the treatment of patients with locally advanced cervical carcinoma. The goals were to determine the superior chemoradiation regimen and to quantitate the relative toxicities. METHODS: All patients had biopsy-proven invasive squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix. Patients underwent standard clinical staging studies and their tumors were found to be International Federation of Gynaecology and Obstetrics stages IIB, III, or IVA. Negative cytologic washings and para-aortic lymph nodes were required for entry. Patients were randomized to receive either standard whole pelvic RT with concurrent 5-FU infusion and bolus CF or the same RT plus oral HU. RESULTS: Of 388 randomized patients, 368 were eligible; 177 were randomized to CF and 191 to HU. Adverse effects were predominantly hematologic or gastrointestinal in both regimens. Severe or life-threatening leukopenia was more common in the HU group (24%) than in the CF group (4%). The difference in progression-free survival (PFS) was statistically significant in favor of the CF group (P = .033). The sites of progression in the two treatment groups were not substantially different. Survival was significantly better for the patients randomized to CF (P = .018). CONCLUSION: This study demonstrates that for patients with locally advanced carcinoma of the cervix, the combination of 5-FU and CF with RT offers patients better PFS and overall survival than HU, and with manageable toxicity.  (+info)

Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. (3/236)

We examined the expression of cytokeratin 20 (CK20) mRNA in the peripheral blood of oral squamous cell carcinoma (SCC) patients by reverse transcriptase polymerase chain reaction (RT-PCR). Eleven out of 12 oral SCC patients showed positive RT-PCR results. However, there is no clear relationship between the haematogenous CK20 mRNA and the metastasis. After initial treatment, all of the tumour-free survivors tested showed negative RT-PCR results. CK20 mRNA in peripheral blood can be used as a marker for tumour recurrence but not not for metastasis in oral SCC patients.  (+info)

A population-based survey of the management of women with cancer of the cervix. (4/236)

The aim of this study was to investigate the influence of diagnostic throughput on survival outcome for women with cancer of the cervix. We conducted a case note review of 359 women in Lancashire and Greater Manchester diagnosed with cancer of the cervix during 1990, identified from records held by the North Western Regional Cancer Registry. Univariate and multivariate survival analyses were undertaken to investigate the influence on survival of woman, disease and treatment related factors. Following adjustment for woman- and disease-related factors there was no evidence of a statistically significant association between diagnostic throughput and survival. The findings of this study do not support the need for any change in the referral patterns to gynaecologists of women with symptoms suggestive of cancer of the cervix.  (+info)

Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. (5/236)

The level of cyclooxygenase (COX)-2 has been investigated recently in various human carcinomas. In the present study, we examined the distribution and extent of COX-2 protein in human pancreatic tumors using immunohistochemistry. A strong expression of COX-2 protein was present in 23 of 52 (44%) pancreatic carcinomas, a moderate expression was present in 24 of 52 (46%) pancreatic carcinomas, and a weak expression was present in 5 of 52 (10%) pancreatic carcinomas. In contrast, benign tumors showed weak expression or no expression of COX-2, and only islet cells displayed COX-2 expression in normal pancreatic tissues. Overexpression of COX-2 in carcinoma tissues was also confirmed by Western blot analysis. Furthermore, consistent with the results at protein levels, reverse transcription-PCR analyses indicated that COX-2 mRNA was overexpressed in 7 of 13 (54%) carcinomas, but in none of 3 benign tumors. Our findings suggest that COX-2 inhibitors might be potentially effective against pancreatic carcinomas and that COX-2 may be involved in certain biological processes in pancreatic islets.  (+info)

Adenosquamous carcinoma of the prostate. (6/236)

An unusual adenosquamous carcinoma originating in the prostate of a 73-year-old man is described. The histological finding showed a well differentiated squamous cell carcinoma admixed in an adenocarcinomatous area. A transitional area of 2 carcinomatous elements was also noted. Seven months prior to the development of this lesion, a diagnosis of adenocarcinoma had been established by transurethral resection of the prostate and the patient had been treated with bilateral orchiectomy. This is the first case of adenosquamous carcinoma of the prostate reported in Korea. The pathogenesis and previous reports of this lesion will be discussed.  (+info)

Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. (7/236)

The MaTu interval (MN)/carbonic anhydrase (CA) IX tumour-associated antigen is a protein that is normally expressed in the gut and belongs to the carbonic anhydrase enzyme family (CA IX). It has been detected in tumour cell lines and in some solid tumours including cervical, oesophageal and clear cell renal carcinoma. This study determined MN/CA IX expression in 65 primary non-small cell lung cancer resected with curative intent and in 38 bronchial preneoplastic lesions, carcinoma in situ or microinvasive carcinoma as well as in normal bronchial tissue. The presence of MN/CA IX was detected using immunohistochemistry and Western blot analysis, whenever frozen material was available. Immunostaining was positive in 52/65 (80%) of the tumour samples. The staining was more often focal than diffuse. The percentage of stained cells in positive tumours was highly variable, ranging 1-85%. The pattern of immunostaining was predominantly cytoplasmic with a membranous reinforcement (87%). The intensity was mainly strong (69%). The presence of the protein in the tumour was confirmed by Western blot analysis in the eight samples tested. All the morphologically normal epithelia, except in close vicinity of tumours in some cases, as well as the preneoplastic bronchial lesions (basal cell hyperplasia, metaplasia and dysplasia) were immunonegative for MN/CA IX expression. In contrast, carcinoma in situ and microinvasive epithelioma showed the presence of MN-immunopositive tumoural cells in 5/7 and 4/5 of the samples, respectively. These data suggest that MN/CA IX is a useful marker for the differentiation between preneoplastic lesions and bronchial non-small cell lung cancer in the lung.  (+info)

Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats. (8/236)

The effects of antibiotics and anti-inflammatory drugs on the promotion stage of lung carcinogenesis initiated with N-nitrosobis(2-hydroxypropyl)amine (BHP) in rats were investigated in two experiments with a similar protocol. In experiment 1, rats received tap water containing 2000 p.p.m. BHP for 12 weeks followed by basal diet or basal diet containing 0.02% erythromycin (EM), 0. 04% ampicillin (ABPC), 1.5% sho-saiko-to, 0.02% EM plus 1.5% sho-saiko-to or 0.04% ABPC plus 1.5% sho-saiko-to for 8 weeks after BHP administration. The development of adenocarcinomas (AC), squamous cell carcinomas (SqC) and adenosquamous carcinomas (ASqC) was completely inhibited in rats given ABPC plus sho-saiko-to and the numbers of lung lesions including alveolar hyperplasias, adenomas and carcinomas were decreased in rats given EM plus sho-saiko-to or ABPC plus sho-saiko-to. Neutrophil and macrophage infiltration into alveolar spaces of the lung were also markedly suppressed. In experiment 2, rats received BHP in the same manner as in experiment 1 and basal diet or basal diet containing 0.04% ABPC, 0.006% piroxicam, 0.04% ABPC plus 0.006% piroxicam and 0.04% ABPC plus 0.75% ougon for 8 weeks. The incidence and number of carcinomas, including ACs, SqCs and ASqCs were decreased in rats given ABPC plus piroxicam or ABPC plus ougon. Bacteria, mainly Escherichia coli, were detected in broncho-alveolar lavage of rats receiving BHP. The results suggest that chronic inflammation might be involved in the progression of lung carcinogenesis by BHP in rats and its suppression may therefore be useful as a chemopreventive strategy in lung cancer clinics.  (+info)

Adenosquamous carcinoma is a rare type of cancer that contains two types of cells: glandular (adeno) and squamous. This mixed composition leads to a unique microscopic appearance and more aggressive behavior compared to other types of carcinomas. Adenosquamous carcinoma can occur in various organs, such as the lung, pancreas, cervix, and skin.

The glandular (adeno) component is made up of columnar epithelial cells that form glands or tubular structures. These cells produce mucus or other secretions. The squamous component consists of flat, scale-like cells that resemble the cells found in the outer layer of the skin.

The presence of both adeno and squamous components in a single tumor can lead to more rapid growth, increased likelihood of metastasis (spreading to other parts of the body), and poorer prognosis compared to carcinomas with only one cell type. Treatment typically involves surgical resection, radiation therapy, chemotherapy, or a combination of these approaches, depending on the location and stage of the cancer.

Carcinoma is a type of cancer that develops from epithelial cells, which are the cells that line the inner and outer surfaces of the body. These cells cover organs, glands, and other structures within the body. Carcinomas can occur in various parts of the body, including the skin, lungs, breasts, prostate, colon, and pancreas. They are often characterized by the uncontrolled growth and division of abnormal cells that can invade surrounding tissues and spread to other parts of the body through a process called metastasis. Carcinomas can be further classified based on their appearance under a microscope, such as adenocarcinoma, squamous cell carcinoma, and basal cell carcinoma.

Squamous cell carcinoma is a type of skin cancer that begins in the squamous cells, which are flat, thin cells that form the outer layer of the skin (epidermis). It commonly occurs on sun-exposed areas such as the face, ears, lips, and backs of the hands. Squamous cell carcinoma can also develop in other areas of the body including the mouth, lungs, and cervix.

This type of cancer usually develops slowly and may appear as a rough or scaly patch of skin, a red, firm nodule, or a sore or ulcer that doesn't heal. While squamous cell carcinoma is not as aggressive as some other types of cancer, it can metastasize (spread) to other parts of the body if left untreated, making early detection and treatment important.

Risk factors for developing squamous cell carcinoma include prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds, fair skin, a history of sunburns, a weakened immune system, and older age. Prevention measures include protecting your skin from the sun by wearing protective clothing, using a broad-spectrum sunscreen with an SPF of at least 30, avoiding tanning beds, and getting regular skin examinations.

Adenocarcinoma is a type of cancer that arises from glandular epithelial cells. These cells line the inside of many internal organs, including the breasts, prostate, colon, and lungs. Adenocarcinomas can occur in any of these organs, as well as in other locations where glands are present.

The term "adenocarcinoma" is used to describe a cancer that has features of glandular tissue, such as mucus-secreting cells or cells that produce hormones. These cancers often form glandular structures within the tumor mass and may produce mucus or other substances.

Adenocarcinomas are typically slow-growing and tend to spread (metastasize) to other parts of the body through the lymphatic system or bloodstream. They can be treated with surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these treatments. The prognosis for adenocarcinoma depends on several factors, including the location and stage of the cancer, as well as the patient's overall health and age.

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults. It originates from the hepatocytes, which are the main functional cells of the liver. This type of cancer is often associated with chronic liver diseases such as cirrhosis caused by hepatitis B or C virus infection, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and aflatoxin exposure.

The symptoms of HCC can vary but may include unexplained weight loss, lack of appetite, abdominal pain or swelling, jaundice, and fatigue. The diagnosis of HCC typically involves imaging tests such as ultrasound, CT scan, or MRI, as well as blood tests to measure alpha-fetoprotein (AFP) levels. Treatment options for Hepatocellular carcinoma depend on the stage and extent of the cancer, as well as the patient's overall health and liver function. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or liver transplantation.

Uterine cervical neoplasms, also known as cervical cancer or cervical dysplasia, refer to abnormal growths or lesions on the lining of the cervix that have the potential to become cancerous. These growths are usually caused by human papillomavirus (HPV) infection and can be detected through routine Pap smears.

Cervical neoplasms are classified into different grades based on their level of severity, ranging from mild dysplasia (CIN I) to severe dysplasia or carcinoma in situ (CIN III). In some cases, cervical neoplasms may progress to invasive cancer if left untreated.

Risk factors for developing cervical neoplasms include early sexual activity, multiple sexual partners, smoking, and a weakened immune system. Regular Pap smears and HPV testing are recommended for early detection and prevention of cervical cancer.

Lung neoplasms refer to abnormal growths or tumors in the lung tissue. These tumors can be benign (non-cancerous) or malignant (cancerous). Malignant lung neoplasms are further classified into two main types: small cell lung carcinoma and non-small cell lung carcinoma. Lung neoplasms can cause symptoms such as cough, chest pain, shortness of breath, and weight loss. They are often caused by smoking or exposure to secondhand smoke, but can also occur due to genetic factors, radiation exposure, and other environmental carcinogens. Early detection and treatment of lung neoplasms is crucial for improving outcomes and survival rates.

Plutonium is not a medical term, but it is a chemical element with the symbol Pu and atomic number 94. It is a dense, silvery-red, transuranic radioactive metal that occurs in minute quantities naturally as an intermediate product of uranium decay, or can be produced by neutron capture in uranium-238.

Plutonium is highly toxic and radioactive, and it has been classified as a Category II carcinogen by the International Agency for Research on Cancer (IARC). It is mainly used in the production of nuclear weapons and as fuel in nuclear reactors. Medical uses of plutonium are limited due to its high radioactivity and toxicity.

In medicine, plutonium-210 has been used in some cancer therapies, such as brachytherapy, where a small amount of the isotope is implanted directly into the tumor. However, due to its high radioactivity and potential for causing radiation damage to surrounding tissues, its use in medicine is highly regulated and relatively rare.

Lacrimal apparatus diseases refer to conditions that affect the structure and function of the lacrimal system, which is responsible for producing, storing, and draining tears. The lacrimal apparatus includes the lacrimal glands, lacrimal canaliculi, lacrimal sac, and nasolacrimal duct.

Diseases of the lacrimal apparatus can cause a range of symptoms, including watery eyes, redness, pain, swelling, and discharge. Some common conditions that affect the lacrimal apparatus include:

1. Dry eye syndrome: A condition in which the lacrimal glands do not produce enough tears or the tears are of poor quality, leading to dryness, irritation, and inflammation of the eyes.
2. Dacryocystitis: An infection of the lacrimal sac that can cause pain, swelling, redness, and discharge from the eye.
3. Nasolacrimal duct obstruction: A blockage in the nasolacrimal duct that can cause watery eyes, discharge, and recurrent infections.
4. Epiphora: Excessive tearing or watering of the eyes due to overflow of tears from the eye because of blocked tear ducts or increased production of tears.
5. Canaliculitis: An infection of the lacrimal canaliculi that can cause swelling, redness, and discharge from the eye.
6. Lacrimal gland tumors: Rare tumors that can affect the lacrimal glands and cause symptoms such as pain, swelling, and protrusion of the eyeball.

Treatment for lacrimal apparatus diseases depends on the specific condition and its severity. Treatment options may include medications, surgery, or a combination of both.

Gallbladder neoplasms refer to abnormal growths in the tissue of the gallbladder, which can be benign or malignant. Benign neoplasms are non-cancerous and typically do not spread to other parts of the body. Malignant neoplasms, also known as gallbladder cancer, can invade nearby tissues and organs and may metastasize (spread) to distant parts of the body. Gallbladder neoplasms can cause symptoms such as abdominal pain, jaundice, and nausea, but they are often asymptomatic until they have advanced to an advanced stage. The exact causes of gallbladder neoplasms are not fully understood, but risk factors include gallstones, chronic inflammation of the gallbladder, and certain inherited genetic conditions.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Duodenogastric reflux (DGR) is a medical condition in which the contents of the duodenum, the first part of the small intestine, flow backward into the stomach. This occurs when the pyloric sphincter, a muscle that separates the stomach and duodenum, fails to function properly, allowing the reflux of duodenal juice into the stomach.

Duodenogastric refluxate typically contains bile acids, digestive enzymes, and other stomach-irritating substances. Chronic DGR can lead to gastritis (inflammation of the stomach lining), ulcers, and other gastrointestinal complications. Symptoms may include abdominal pain, bloating, nausea, vomiting, heartburn, and indigestion. Treatment usually involves medications that reduce acid production or neutralize stomach acid, as well as lifestyle modifications to minimize reflux triggers.

Carcinoma in situ is a medical term used to describe the earliest stage of cancer, specifically a type of cancer that begins in the epithelial tissue, which is the tissue that lines the outer surfaces of organs and body structures. In this stage, the cancer cells are confined to the layer of cells where they first developed and have not spread beyond that layer into the surrounding tissues or organs.

Carcinoma in situ can occur in various parts of the body, including the skin, cervix, breast, lung, prostate, bladder, and other areas. It is often detected through routine screening tests, such as Pap smears for cervical cancer or mammograms for breast cancer.

While carcinoma in situ is not invasive, it can still be a serious condition because it has the potential to develop into an invasive cancer if left untreated. Treatment options for carcinoma in situ may include surgery, radiation therapy, or other forms of treatment, depending on the location and type of cancer. It is important to consult with a healthcare provider to determine the best course of action for each individual case.

Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.

Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.

Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.

There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.

A pancreatectomy is a surgical procedure in which all or part of the pancreas is removed. There are several types of pancreatectomies, including:

* **Total pancreatectomy:** Removal of the entire pancreas, as well as the spleen and nearby lymph nodes. This type of pancreatectomy is usually done for patients with cancer that has spread throughout the pancreas or for those who have had multiple surgeries to remove pancreatic tumors.
* **Distal pancreatectomy:** Removal of the body and tail of the pancreas, as well as nearby lymph nodes. This type of pancreatectomy is often done for patients with tumors in the body or tail of the pancreas.
* **Partial (or segmental) pancreatectomy:** Removal of a portion of the head or body of the pancreas, as well as nearby lymph nodes. This type of pancreatectomy is often done for patients with tumors in the head or body of the pancreas that can be removed without removing the entire organ.
* **Pylorus-preserving pancreaticoduodenectomy (PPPD):** A type of surgery used to treat tumors in the head of the pancreas, as well as other conditions such as chronic pancreatitis. In this procedure, the head of the pancreas, duodenum, gallbladder, and bile duct are removed, but the stomach and lower portion of the esophagus (pylorus) are left in place.

After a pancreatectomy, patients may experience problems with digestion and blood sugar regulation, as the pancreas plays an important role in these functions. Patients may need to take enzyme supplements to help with digestion and may require insulin therapy to manage their blood sugar levels.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Neoplasm staging is a systematic process used in medicine to describe the extent of spread of a cancer, including the size and location of the original (primary) tumor and whether it has metastasized (spread) to other parts of the body. The most widely accepted system for this purpose is the TNM classification system developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).

In this system, T stands for tumor, and it describes the size and extent of the primary tumor. N stands for nodes, and it indicates whether the cancer has spread to nearby lymph nodes. M stands for metastasis, and it shows whether the cancer has spread to distant parts of the body.

Each letter is followed by a number that provides more details about the extent of the disease. For example, a T1N0M0 cancer means that the primary tumor is small and has not spread to nearby lymph nodes or distant sites. The higher the numbers, the more advanced the cancer.

Staging helps doctors determine the most appropriate treatment for each patient and estimate the patient's prognosis. It is an essential tool for communication among members of the healthcare team and for comparing outcomes of treatments in clinical trials.

Tumor markers are substances that can be found in the body and their presence can indicate the presence of certain types of cancer or other conditions. Biological tumor markers refer to those substances that are produced by cancer cells or by other cells in response to cancer or certain benign (non-cancerous) conditions. These markers can be found in various bodily fluids such as blood, urine, or tissue samples.

Examples of biological tumor markers include:

1. Proteins: Some tumor markers are proteins that are produced by cancer cells or by other cells in response to the presence of cancer. For example, prostate-specific antigen (PSA) is a protein produced by normal prostate cells and in higher amounts by prostate cancer cells.
2. Genetic material: Tumor markers can also include genetic material such as DNA, RNA, or microRNA that are shed by cancer cells into bodily fluids. For example, circulating tumor DNA (ctDNA) is genetic material from cancer cells that can be found in the bloodstream.
3. Metabolites: Tumor markers can also include metabolic products produced by cancer cells or by other cells in response to cancer. For example, lactate dehydrogenase (LDH) is an enzyme that is released into the bloodstream when cancer cells break down glucose for energy.

It's important to note that tumor markers are not specific to cancer and can be elevated in non-cancerous conditions as well. Therefore, they should not be used alone to diagnose cancer but rather as a tool in conjunction with other diagnostic tests and clinical evaluations.

Carcinoma, papillary is a type of cancer that begins in the cells that line the glandular structures or the lining of organs. In a papillary carcinoma, the cancerous cells grow and form small finger-like projections, called papillae, within the tumor. This type of cancer most commonly occurs in the thyroid gland, but can also be found in other organs such as the lung, breast, and kidney. Papillary carcinoma of the thyroid gland is usually slow-growing and has a good prognosis, especially when it is diagnosed at an early stage.

Papillomaviridae is a family of small, non-enveloped DNA viruses that primarily infect the epithelial cells of mammals, birds, and reptiles. The name "papillomavirus" comes from the Latin word "papilla," which means nipple or small projection, reflecting the characteristic wart-like growths (papillomas) that these viruses can cause in infected host tissues.

The family Papillomaviridae includes more than 200 distinct papillomavirus types, with each type being defined by its specific DNA sequence. Human papillomaviruses (HPVs), which are the most well-studied members of this family, are associated with a range of diseases, from benign warts and lesions to malignant cancers such as cervical, anal, penile, vulvar, and oropharyngeal cancers.

Papillomaviruses have a circular, double-stranded DNA genome that is approximately 8 kbp in size. The viral genome encodes several early (E) proteins involved in viral replication and oncogenesis, as well as late (L) proteins that form the viral capsid. The life cycle of papillomaviruses is tightly linked to the differentiation program of their host epithelial cells, with productive infection occurring primarily in the differentiated layers of the epithelium.

In summary, Papillomaviridae is a family of DNA viruses that infect epithelial cells and can cause a variety of benign and malignant diseases. Human papillomaviruses are a significant public health concern due to their association with several cancer types.

Medical survival rate is a statistical measure used to determine the percentage of patients who are still alive for a specific period of time after their diagnosis or treatment for a certain condition or disease. It is often expressed as a five-year survival rate, which refers to the proportion of people who are alive five years after their diagnosis. Survival rates can be affected by many factors, including the stage of the disease at diagnosis, the patient's age and overall health, the effectiveness of treatment, and other health conditions that the patient may have. It is important to note that survival rates are statistical estimates and do not necessarily predict an individual patient's prognosis.

Liver neoplasms refer to abnormal growths in the liver that can be benign or malignant. Benign liver neoplasms are non-cancerous tumors that do not spread to other parts of the body, while malignant liver neoplasms are cancerous tumors that can invade and destroy surrounding tissue and spread to other organs.

Liver neoplasms can be primary, meaning they originate in the liver, or secondary, meaning they have metastasized (spread) to the liver from another part of the body. Primary liver neoplasms can be further classified into different types based on their cell of origin and behavior, including hepatocellular carcinoma, cholangiocarcinoma, and hepatic hemangioma.

The diagnosis of liver neoplasms typically involves a combination of imaging studies, such as ultrasound, CT scan, or MRI, and biopsy to confirm the type and stage of the tumor. Treatment options depend on the type and extent of the neoplasm and may include surgery, radiation therapy, chemotherapy, or liver transplantation.

Microdissection is a surgical technique that involves the use of a microscope to allow for precise, minimalistic dissection of tissue. It is often used in research and clinical settings to isolate specific cells, tissues or structures while minimizing damage to surrounding areas. This technique can be performed using various methods such as laser capture microdissection (LCM) or manual microdissection with microsurgical tools. The size and scale of the dissection required will determine the specific method used. In general, microdissection allows for the examination and analysis of very small and delicate structures that would otherwise be difficult to access and study.

Carcinoma, ductal, breast is a type of breast cancer that begins in the milk ducts (the tubes that carry milk from the lobules of the breast to the nipple). It is called "ductal" because it starts in the cells that line the milk ducts. Ductal carcinoma can be further classified as either non-invasive or invasive, based on whether the cancer cells are confined to the ducts or have spread beyond them into the surrounding breast tissue.

Non-invasive ductal carcinoma (also known as intraductal carcinoma or ductal carcinoma in situ) is a condition where abnormal cells have been found in the lining of the milk ducts, but they have not spread outside of the ducts. These cells have the potential to become invasive and spread to other parts of the breast or body if left untreated.

Invasive ductal carcinoma (IDC) is a type of breast cancer that starts in a milk duct and then grows into the surrounding breast tissue. From there, it can spread to other parts of the body through the bloodstream and lymphatic system. IDC is the most common form of breast cancer, accounting for about 80% of all cases.

Symptoms of ductal carcinoma may include a lump or thickening in the breast, changes in the size or shape of the breast, dimpling or puckering of the skin on the breast, nipple discharge (especially if it is clear or bloody), and/or redness or scaling of the nipple or breast skin. However, many cases of ductal carcinoma are detected through mammography before any symptoms develop.

Treatment for ductal carcinoma depends on several factors, including the stage and grade of the cancer, as well as the patient's overall health and personal preferences. Treatment options may include surgery (such as a lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, and/or targeted therapies.

Keratins are a type of fibrous structural proteins that constitute the main component of the integumentary system, which includes the hair, nails, and skin of vertebrates. They are also found in other tissues such as horns, hooves, feathers, and reptilian scales. Keratins are insoluble proteins that provide strength, rigidity, and protection to these structures.

Keratins are classified into two types: soft keratins (Type I) and hard keratins (Type II). Soft keratins are found in the skin and simple epithelial tissues, while hard keratins are present in structures like hair, nails, horns, and hooves.

Keratin proteins have a complex structure consisting of several domains, including an alpha-helical domain, beta-pleated sheet domain, and a non-repetitive domain. These domains provide keratin with its unique properties, such as resistance to heat, chemicals, and mechanical stress.

In summary, keratins are fibrous structural proteins that play a crucial role in providing strength, rigidity, and protection to various tissues in the body.

Carcinoma, basal cell is a type of skin cancer that arises from the basal cells, which are located in the lower part of the epidermis (the outermost layer of the skin). It is also known as basal cell carcinoma (BCC) and is the most common form of skin cancer.

BCC typically appears as a small, shiny, pearly bump or nodule on the skin, often in sun-exposed areas such as the face, ears, neck, hands, and arms. It may also appear as a scar-like area that is white, yellow, or waxy. BCCs are usually slow growing and rarely spread (metastasize) to other parts of the body. However, they can be locally invasive and destroy surrounding tissue if left untreated.

The exact cause of BCC is not known, but it is thought to be related to a combination of genetic and environmental factors, including exposure to ultraviolet (UV) radiation from the sun or tanning beds. People with fair skin, light hair, and blue or green eyes are at increased risk of developing BCC.

Treatment for BCC typically involves surgical removal of the tumor, along with a margin of healthy tissue. Other treatment options may include radiation therapy, topical chemotherapy, or photodynamic therapy. Prevention measures include protecting your skin from UV radiation by wearing protective clothing, using sunscreen, and avoiding tanning beds.

Carcinoma, non-small-cell lung (NSCLC) is a type of lung cancer that includes several subtypes of malignant tumors arising from the epithelial cells of the lung. These subtypes are classified based on the appearance of the cancer cells under a microscope and include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC accounts for about 85% of all lung cancers and tends to grow and spread more slowly than small-cell lung cancer (SCLC).

NSCLC is often asymptomatic in its early stages, but as the tumor grows, symptoms such as coughing, chest pain, shortness of breath, hoarseness, and weight loss may develop. Treatment options for NSCLC depend on the stage and location of the cancer, as well as the patient's overall health and lung function. Common treatments include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches.

Lymphatic metastasis is the spread of cancer cells from a primary tumor to distant lymph nodes through the lymphatic system. It occurs when malignant cells break away from the original tumor, enter the lymphatic vessels, and travel to nearby or remote lymph nodes. Once there, these cancer cells can multiply and form new tumors, leading to further progression of the disease. Lymphatic metastasis is a common way for many types of cancer to spread and can have significant implications for prognosis and treatment strategies.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Papillomavirus infections are a group of diseases caused by various types of human papillomaviruses (HPVs). These viruses infect the skin and mucous membranes, and can cause benign growths such as warts or papillomas, as well as malignant growths like cervical cancer.

There are more than 100 different types of HPVs, and they can be classified into low-risk and high-risk types based on their potential to cause cancer. Low-risk HPV types, such as HPV-6 and HPV-11, commonly cause benign genital warts and respiratory papillomas. High-risk HPV types, such as HPV-16 and HPV-18, are associated with an increased risk of developing cancer, including cervical, anal, penile, vulvar, and oropharyngeal cancers.

HPV infections are typically transmitted through sexual contact, and most sexually active individuals will acquire at least one HPV infection during their lifetime. In many cases, the immune system is able to clear the virus without any symptoms or long-term consequences. However, persistent high-risk HPV infections can lead to the development of cancer over time.

Prevention measures for HPV infections include vaccination against high-risk HPV types, safe sex practices, and regular screening for cervical cancer in women. The HPV vaccine is recommended for both boys and girls aged 11-12 years old, and can also be given to older individuals up to age 45 who have not previously been vaccinated or who have not completed the full series of shots.

Pancreaticoduodenectomy, also known as the Whipple procedure, is a complex surgical operation that involves the removal of the head of the pancreas, the duodenum (the first part of the small intestine), the gallbladder, and the distal common bile duct. In some cases, a portion of the stomach may also be removed. The remaining parts of the pancreas, bile duct, and intestines are then reconnected to allow for the digestion of food and drainage of bile.

This procedure is typically performed as a treatment for various conditions affecting the pancreas, such as tumors (including pancreatic cancer), chronic pancreatitis, or traumatic injuries. It is a major surgical operation that requires significant expertise and experience to perform safely and effectively.

The Epidermal Growth Factor Receptor (EGFR) is a type of receptor found on the surface of many cells in the body, including those of the epidermis or outer layer of the skin. It is a transmembrane protein that has an extracellular ligand-binding domain and an intracellular tyrosine kinase domain.

EGFR plays a crucial role in various cellular processes such as proliferation, differentiation, migration, and survival. When EGF (Epidermal Growth Factor) or other ligands bind to the extracellular domain of EGFR, it causes the receptor to dimerize and activate its intrinsic tyrosine kinase activity. This leads to the autophosphorylation of specific tyrosine residues on the receptor, which in turn recruits and activates various downstream signaling molecules, resulting in a cascade of intracellular signaling events that ultimately regulate gene expression and cell behavior.

Abnormal activation of EGFR has been implicated in several human diseases, including cancer. Overexpression or mutation of EGFR can lead to uncontrolled cell growth and division, angiogenesis, and metastasis, making it an important target for cancer therapy.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Transitional cell carcinoma (TCC) is a type of cancer that develops in the transitional epithelium, which is the tissue that lines the inner surface of the urinary tract. This includes the renal pelvis, ureters, bladder, and urethra. Transitional cell carcinoma is the most common type of bladder cancer and can also occur in other parts of the urinary system.

Transitional cells are specialized epithelial cells that can stretch and change shape as the organs they line expand or contract. These cells normally have a flat, squamous appearance when at rest but become more cuboidal and columnar when the organ is full. Transitional cell carcinomas typically start in the urothelium, which is the innermost lining of the urinary tract.

Transitional cell carcinoma can be classified as non-invasive (also called papillary or superficial), invasive, or both. Non-invasive TCCs are confined to the urothelium and have not grown into the underlying connective tissue. Invasive TCCs have grown through the urothelium and invaded the lamina propria (a layer of connective tissue beneath the urothelium) or the muscle wall of the bladder.

Transitional cell carcinoma can also be categorized as low-grade or high-grade, depending on how abnormal the cancer cells look under a microscope and how likely they are to grow and spread. Low-grade TCCs tend to have a better prognosis than high-grade TCCs.

Treatment for transitional cell carcinoma depends on the stage and grade of the cancer, as well as other factors such as the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, or immunotherapy.

Morbidity, in medical terms, refers to the state or condition of being diseased or unhealthy. It is used to describe the incidence or prevalence of a particular disease or health condition within a population, or the presence of multiple diseases or health conditions in an individual. Morbidity can also refer to the complications or symptoms associated with a disease or injury. In clinical settings, morbidity may be used to assess a patient's overall health status and their response to treatment.

DNA Mutational Analysis is a laboratory test used to identify genetic variations or changes (mutations) in the DNA sequence of a gene. This type of analysis can be used to diagnose genetic disorders, predict the risk of developing certain diseases, determine the most effective treatment for cancer, or assess the likelihood of passing on an inherited condition to offspring.

The test involves extracting DNA from a patient's sample (such as blood, saliva, or tissue), amplifying specific regions of interest using polymerase chain reaction (PCR), and then sequencing those regions to determine the precise order of nucleotide bases in the DNA molecule. The resulting sequence is then compared to reference sequences to identify any variations or mutations that may be present.

DNA Mutational Analysis can detect a wide range of genetic changes, including single-nucleotide polymorphisms (SNPs), insertions, deletions, duplications, and rearrangements. The test is often used in conjunction with other diagnostic tests and clinical evaluations to provide a comprehensive assessment of a patient's genetic profile.

It is important to note that not all mutations are pathogenic or associated with disease, and the interpretation of DNA Mutational Analysis results requires careful consideration of the patient's medical history, family history, and other relevant factors.

... is a type of cancer that contains two types of cells: squamous cells (thin, flat cells that line ... Adenosquamous carcinoma entry in the public domain NCI Dictionary of Cancer Terms This article incorporates public domain ... February 2010). "Adenosquamous carcinoma of the pancreas: a case report". Cases Journal. 3 (1): 41. doi:10.1186/1757-1626-3-41 ... Di Como JA (October 2015). "Adenosquamous carcinoma of the colon and rectum: a population based clinical outcomes study ...
Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... Adenosquamous lung carcinoma (AdSqLC) is a biphasic malignant tumor arising from lung tissue that is composed of at least 10% ... In the 1960s, small cell lung carcinoma (SCLC) was recognized as a unique form of lung cancer, based both on its appearance ( ... Approximately 98% of lung cancers are carcinoma, which are tumors composed of cells with epithelial characteristics. LCLC's are ...
Other, rarer types include lymphoma, adenosquamous and squamous cell carcinoma. Some subtypes have been found to be more ... Di Como, Joseph A. (October 2015). "Adenosquamous carcinoma of the colon and rectum: a population based clinical outcomes study ... B) Squamous carcinoma: morphologically similar to other squamous cell carcinomas occurring in other organs with possible ... H&E stained sections: (A) Villous carcinoma: invasive carcinoma with villous features consisting of usually intraglandular ...
Di Como JA, Mahendraraj K, Lau CS, Chamberlain RS (October 2015). "Adenosquamous carcinoma of the colon and rectum: a ... Other, rarer types include lymphoma, adenosquamous and squamous cell carcinoma. Some subtypes are more aggressive. ... Comprehensive, genome-scale analysis has revealed that colorectal carcinomas can be categorized into hypermutated and non- ... "TNM staging of colorectal carcinoma (AJCC 8th edition)". www.pathologyoutlines.com. Retrieved February 24, 2019. Parkin DM, ...
"The prognosis of adenosquamous carcinomas of the uterine cervix". BJOG: An International Journal of Obstetrics and Gynaecology ... "Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study". Pathology. ...
Bannatyne P, Elliott P, Russell P (December 1989). "Vulvar adenosquamous carcinoma arising in a hidradenoma papilliferum, with ... and one case was a rapidly fatal lesion that appeared to be an adenosquamous carcinoma that arose in a papillary hidradenoma. ... and squamous cell carcinoma. Furthermore, benign papillary hidradenoma tumors may be confused clinically with cancerous tumors ... squamous cell carcinomas, nodular lesions in extramammary Paget disease, dermatofibroma, focal areas of mucinosis, colloid ...
... and adenosquamous carcinoma. The mixed-type is further classified as carcinoma with chondroid metaplasia, carcinoma with ... Metaplastic carcinoma, otherwise known as metaplastic carcinoma of the breast (MCB), is a heterogeneous group of cancers that ... invasive ductal carcinoma with extensive squamous metaplasia, and invasive ductal carcinoma with pseudosarcomatous metaplasia. ... Böler DE, Kara H, Sağlıcan Y, Tokat F, Uras C (2016-08-01). "Metaplastic carcinoma of the breast: A case series and review of ...
... and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia ... Thomas DB, Ye Z, Ray RM (January 1995). "Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO ...
... or adenosquamous carcinomas.[medical citation needed] Because CUP refers to many different cancers, treatment depends on where ... A PET CT scan should be done for squamous cell carcinoma involving lymph nodes of the neck region. For other types of cancer of ... Krishnatreya M, Sharma JD, Kataki AC, Kalita M (2014). "Survival in carcinoma of unknown primary to neck nodes treated with ... Varadhachary, Gauri R. (2007). "Carcinoma of Unknown Primary Origin". Gastrointestinal Cancer Research. 1 (6): 229-235. ISSN ...
These include mixes of the above subtypes like adenosquamous carcinoma, and rare subtypes such as carcinoid tumors, and ... NSCLCs comprise a group of three cancer types: adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma. Nearly 40% of ... squamous-cell carcinomas, and large-cell carcinomas. After diagnosis, further imaging and biopsies are done to determine the ... Lung cancer, also known as lung carcinoma, is a malignant tumor that begins in the lung. Lung cancer is caused by genetic ...
Other exocrine cancers include adenosquamous carcinomas, signet ring cell carcinomas, hepatoid carcinomas, colloid carcinomas, ... undifferentiated carcinomas, and undifferentiated carcinomas with osteoclast-like giant cells. Solid pseudopapillary tumor is a ... The next-most common type, acinar cell carcinoma of the pancreas, arises in the clusters of cells that produce these enzymes, ... Like the 'functioning' endocrine cancers described below, acinar cell carcinomas may cause over-production of certain molecules ...
Adenosquamous carcinoma Refers to a mixed tumor containing both adenocarcinoma and squamous cell carcinoma, wherein each of ... In some types of carcinomas, Stage 0 carcinoma has been used to describe carcinoma in situ, and occult carcinomas detectable ... Some carcinomas are named for their or the putative cell of origin, (e.g.hepatocellular carcinoma, renal cell carcinoma). ... and sarcomatoid carcinoma (mixtures of spindle and giant cell carcinoma). Pleomorphic carcinoma contains spindle cell and/or ...
Adenosquamous carcinoma Small cell carcinoma Neuroendocrine tumour Glassy cell carcinoma Villoglandular adenocarcinoma Invasive ... Histologic subtypes of invasive cervical carcinoma include: Squamous cell carcinoma (about 80-85%) adenocarcinoma (about 15% of ... Though squamous cell carcinoma is the cervical cancer with the most incidence, the incidence of adenocarcinoma of the cervix ... Dürst M, Gissmann L, Ikenberg H, zur Hausen H (June 1983). "A papillomavirus DNA from a cervical carcinoma and its prevalence ...
... carcinoma, adenosquamous MeSH C04.557.470.200.165 - carcinoma, basal cell MeSH C04.557.470.200.165.150 - basal cell nevus ... carcinoma, adenosquamous MeSH C04.557.435.290 - carcinosarcoma MeSH C04.557.435.290.210 - carcinoma 256, walker MeSH C04.557. ... carcinoma, ehrlich tumor MeSH C04.557.470.200.220 - carcinoma, giant cell MeSH C04.557.470.200.240 - carcinoma in situ MeSH ... carcinoma, large cell MeSH C04.557.470.200.280 - carcinoma, lewis lung MeSH C04.557.470.200.300 - carcinoma, non-small-cell ...
Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... pleomorphic carcinoma, (2) spindle cell carcinoma, (3) giant cell carcinoma, (4) carcinosarcoma, or (5) pulmonary blastoma. ... Carcinoid tumor Salivary gland-like carcinoma Sarcomatoid carcinomas are unique among lung carcinomas in that, although they ... Sarcomatoid carcinoma of the lung is a term that encompasses five distinct histological subtypes of lung cancer, including (1) ...
Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... combined small cell carcinoma of the lung has been long classified as a subset of small cell carcinoma, and not as a subset of ... and giant cell carcinoma. Giant cell carcinoma components are seen much more commonly in patients who have undergone radiation ... reports the finding of small cell carcinoma, regardless of other components, because small cell carcinoma is considered the ...
... cell lung carcinoma Small cell lung carcinoma Adenocarcinoma of the lung Large cell lung carcinoma Adenosquamous carcinoma ... squamous cell carcinoma, combined large cell neuroencrine carcinoma, and mucinous bronchioloalveolar carcinoma and combined ... Similar to nearly all variants of lung carcinoma, large cell lung carcinoma with rhabdoid phenotype appears to be highly ... carcinoma Carcinoid tumor Salivary gland-like carcinoma of the lung LCLC-RP are considered variants of large cell carcinoma. ...
Oncocytic adrenal cortical carcinoma Myxoid adrenal cortical carcinoma Carcinosarcoma Adenosquamous adrenocortical carcinoma ... Adrenocortical adenoma Renal cell carcinoma Pheochromocytoma Hepatocellular carcinoma Adrenocortical carcinomas are most ... Adrenocortical carcinoma has often invaded nearby tissues or metastasized to distant organs at the time of diagnosis, and the ... Adrenocortical carcinoma (ACC) is an aggressive cancer originating in the cortex (steroid hormone-producing tissue) of the ...
Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... adenoid cystic carcinoma of the lung, epithelial-myoepithelial carcinoma of the lung, and other (even more rare) variants. Lung ... Salivary gland-like carcinomas of the lung generally refers a class of rare cancers that arise from the uncontrolled cell ... Carcinoma is a term for malignant neoplasms derived from cells of epithelial lineage, and/or that exhibit cytological or tissue ...
... carcinoma Adenosquamous carcinoma Glassy cell carcinoma Adenoid cystic carcinoma Adenoid basal carcinoma Small cell carcinoma ... Also called carcinoma in situ (CIS). The carcinoma has grown into the cervix, but has not spread beyond it (extension to the ... If the specimen is not satisfactory, a small loop biopsy or cone may be required.[citation needed] The carcinoma is confined to ... There are 10 histopathologic types of cervical cancers: Squamous cell carcinoma (keratinizing; non-keratinizing; papillary, ...
Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... In the lung, two salivary gland-like carcinomas, mucoepidermoid carcinoma and adenoid cystic carcinoma, while extremely ... Epithelial-myoepithelial carcinoma of the lung is a very rare histologic form of malignant epithelial neoplasm ("carcinoma") ... March 2010). "肺に発生した上皮-筋上皮癌" [Epithelial-myoepithelial carcinoma of the lung]. Kyobu Geka (in Japanese). 63 (3): 220-3. PMID ...
Small-cell carcinoma Squamous cell carcinoma Adenocarcinoma Large-cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... Giant-cell carcinoma of the lung (GCCL) is a rare histological form of large-cell lung carcinoma, a subtype of undifferentiated ... Only small-cell carcinoma and large-cell carcinoma had shorter average survival.) Most GCCL have already grown and invaded ... including squamous cell carcinoma, and spindle cell carcinoma. The overall five-year survival rate in GCCL varies between ...
M8560/3 Adenosquamous carcinoma Mixed adenocarcinoma and squamous cell carcinoma Mixed adenocarcinoma and epidermoid carcinoma ... NOS Reserve cell carcinoma Round cell carcinoma Small cell neuroendocrine carcinoma M8042/3 Oat cell carcinoma (C34._) M8043/3 ... Renal cell carcinoma, spindle cell M8319/3 collecting duct carcinoma (C64.9) Bellini duct carcinoma Renal carcinoma, collecting ... NOS Condylomatous carcinoma Verrucous squamous cell carcinoma Verrucous epidermoid carcinoma Warty carcinoma M8052/0 Squamous ...
Adenosquamous carcinoma is a type of cancer that contains two types of cells: squamous cells (thin, flat cells that line ... Adenosquamous carcinoma entry in the public domain NCI Dictionary of Cancer Terms This article incorporates public domain ... February 2010). "Adenosquamous carcinoma of the pancreas: a case report". Cases Journal. 3 (1): 41. doi:10.1186/1757-1626-3-41 ... Di Como JA (October 2015). "Adenosquamous carcinoma of the colon and rectum: a population based clinical outcomes study ...
adenosquamous-carcinoma-of-the-gallbladder.html · adenosquamous-carcinoma-of-the-pancreas.html · adenosquamous-carcinoma-of-the ... Adenosquamous Carcinoma of the Pancreas is a type of Pancreatic Cancer. title Adenosquamous Carcinoma of the Pancreas type ...
... , Peng Chen, Di Ma,Ruokun Li, ... Liver transplantation for primary intrahepatic adenosquamous carcinoma using a marginal graft. Peng Chen1, Di Ma2, Ruokun Li3, ... Primary adenosquamous carcinoma of liver resected by right trisegmentectomy: report of a case and review of the literature. J ... Rao N. Adenosquamous carcinoma. Semin Diagn Pathol. 2014;31:271-277. [Crossref][Google scholar][Pubmed] ...
... patients and six primary hepatic adenosquamous carcinoma (ASC) patients from January 1998 to December 2011 in Eastern ... Meanwhile, 40 hepatocellular carcinoma (HCC) patients and 26 metastatic hepatic SCC or ASC patients who were hospitalized in ... We reviewed the clinical features and outcomes of three primary hepatic squamous cell carcinoma (SCC) ... There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary ...
They account for 5-6% of cervical carcinomas.. Adenosquamous carcinoma. *. This variant is composed of glandular and squamous ... Ferry JA, Scully RE. Adenoid cystic carcinoma and adenoid basal carcinoma of the uterine cervix. A study of 28 cases. Am J Surg ... Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma ... SQUAMOUS CELL CARCINOMA (SCC). SCC - An invasive carcinoma composed of squamous cells of varying differentiation.[1] It is the ...
Invasive Carcinoma. Invasive ductal carcinoma. Invasive ductal carcinoma is the most commonly diagnosed breast cancer and has a ... Squamous cell carcinoma of ductal origin * Adenosquamous carcinoma * Carcinoma with pseudosarcomatous metaplasia ... Invasive lobular carcinoma. Invasive lobular carcinoma has a much lower incidence than infiltrating ductal carcinoma, ... Ductal Carcinoma In Situ. Ductal carcinoma in situ (DCIS) is noninvasive breast cancer that is limited to the inside of the ...
Riquet, M. et al.Do patients with adenosquamous carcinoma of the lung need a more aggressive approach? J Thorac Cardiovasc Surg ... Lin, G. et al.Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma. Ann Oncol31, 517-524 (2020). ... Adenosquamous carcinoma (ASC) is a rare entity of non-small-cell lung cancer (NSCLC) with an incidence of 0.4% to 4% of all ... Maeda, H. et al.Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases. ...
... adenocarcinoma or adenosquamous histology immediately after at the very least on prior platinum-based chemotherapy for ... ients with recurrent unresectable or metastatic cervix carcinoma with squamous cell, ... ients with recurrent unresectable or metastatic cervix carcinoma with squamous cell, adenocarcinoma or adenosquamous histology ... ients with recurrent unresectable or metastatic cervix carcinoma with squamous cell, adenocarcinoma or adenosquamous histology ...
415 patients with adenosquamous carcinoma of the pancreas: A population-based analysis of prognosis and survival. Journal of ... 415 patients with adenosquamous carcinoma of the pancreas : A population-based analysis of prognosis and survival. In: Journal ... 415 patients with adenosquamous carcinoma of the pancreas: A population-based analysis of prognosis and survival. / Boyd, Casey ... Background: Adenosquamous carcinoma of the pancreas is rare. Our understanding of the disease and its prognosis comes mainly ...
Adenosquamous carcinoma of the ampulla of Vater is a rare disease with a dismal prognosis. Surgical intervention does not ... The final diagnosis was adenosquamous carcinoma of the ampulla of Vater, T3N1M0, stage IIB. Although R0 resection was performed ... Upon reviewing the medical records of our institute, we identified 4 patients who were diagnosed with adenosquamous carcinoma ... Although some published studies have analyzed and discussed adenosquamous carcinomas, hybrid malignancy of the ampulla of Vater ...
Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occur in the body of the ... Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review. World J ... Adenosquamous carcinoma of the pancreas. Digestion. 2005. 72 (2-3):104-8. [QxMD MEDLINE Link]. ... adenosquamous carcinoma (ASCP) , and cystadenocarcinoma (serous and mucinous types). Rare pancreatic malignancies include the ...
Thirty-eight patients with surgically treated stage IB adenosquamous carcinoma of the uterine cervix (AS) have been matched ... A matched study of surgically treated stage IB adenosquamous carcinoma and adenocarcinoma of the uterine cervix ... A matched study of surgically treated stage IB adenosquamous carcinoma and adenocarcinoma of the uterine cervix ...
We operated on two cases of adenosquamous carcinoma of the pancreas, which we present alongside the operation and treatment ... Two case reports of adenosquamous carcinoma of the pancreas are described here, which both underwent surgery resection. The ... are adenosquamous carcinomas of the pancreas. Due to limited data, preoperative diagnosis is a great challenge for physicians, ... and the post-operational histology analysis revealed adenosquamous carcinoma of the pancreas head. The patients were discharged ...
Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occur in the body of the ... Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review. World J ... Adenosquamous carcinoma of the pancreas. Digestion. 2005. 72 (2-3):104-8. [QxMD MEDLINE Link]. ... Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis. J Gastrointest Surg. 2011 Jan. 15 (1 ...
... associated with adenosquamous lung carcinoma Human Disease. DO ID adenosquamous lung carcinoma. DOID:4829 ...
Renal cell carcinoma and brain metastasis: Questioning the dogma of role for cytoreductive nephrectomy. Urologic oncology, 37 3 ... Mammary analogue secretory carcinoma presenting with cervical lymphadenopathy: A rare case report with review of the literature ... Adenosquamous Carcinoma. Adrenal Cancer. Adrenal Cortex Cancers. Adrenal Gland Cancers. Adrenal Rest Tumor ...
Immunohistochemical and HPV-related features of laryngeal adenosquamous carcinoma. Lovato A, Staffieri A, Marino F, Cappellesso ... Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due ... Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression. Lionello M, ...
I am/have/hadadenosquamous carcinoma. I am/have/hadcarcinosarcoma. I am/have/hadlymph node biopsy. ... A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma To confirm the ... Cyclin D1 Based TPF(Docetaxel, Cisplatin and 5-fluorouracil) Induction Chemotherapy for OSCC(Oral Squamous Cell Carcinoma) ... mitomycin in newly diagnosed Anal Squamous Cell Carcinoma (ASCC) patients. The primary objectives are: Phase 1 - is to ...
The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nat. Med. 20, 596-598 (2014). ...
Researchers Report on Comprehensive Analysis of Adenosquamous Carcinoma of the Pancreas. In a comprehensive analysis of ... FDA Pipeline: Priority Reviews in EGFR-Mutant Lung Cancer, Advanced Renal Cell Carcinoma; Fast Track Designations in CLL and ... granted Priority Review to treatments for EGFR-mutant lung cancer and advanced renal cell carcinoma; granted Fast Track ... adenosquamous cancer of the pancreas in preclinical models, researchers identified potential therapeutic targets for this ...
... including adeno-squamous, endometriod, and malignant mixed mullerian tumour, have also been reported [2]. ... uterine cervix carcinoma, uterine cervix epithelium, uterine cervix erosion, uterine tube carcinoma ... Simultaneous Squamous Cell Carcinoma of Cervix and Fallopian Tube; A Case Report. Publication Type : Journal Article ... Abstract : We report a case of simultaneous Squamous cell carcinoma(SCC) of cervix and fallopian tube (invasive). Primary ...
Adenosquamous carcinoma of the oral cavitiy: a rare epithelial malignancy. A report of two cases and review of literature. 2015 ... Mohammed N Islam, Chehal H, Islam S, Housley-Smith M, Bhattacharyya I. Merkel cell carcinoma of the buccal mucosa and lower lip ...
i] AC, adenocarcinoma; SCC, squamous cell carcinoma; ASC, adenosquamous carcinoma; LCC, large cell carcinoma. ... Hamasaki H, Koga K, Aoki M, et al: Expression of laminin 5-γ2 chain in cutaneous squamous cell carcinoma and its role in tumour ... It has been reported that gefitinib inhibits the growth of hepatocellular carcinoma cells, Ln5 reduces the ability of gefitinib ... Another in vitro study performed using A431 cutaneous squamous cell carcinoma cells reported that Ln5-γ2 siRNA significantly ...
Breast cancer Fine-needle aspiration Low-grade adenosquamous carcinoma Low-grade adenosquamous carcinomas (LGASCs) are a rare ... Open the PDF for Fine-Needle Aspiration of Low-Grade Adenosquamous Carcinomas of the Breast: A Report of Three New Cases in ... View article titled, Fine-Needle Aspiration of Low-Grade Adenosquamous Carcinomas of the Breast: A Report of Three New Cases ... Fine-Needle Aspiration of Low-Grade Adenosquamous Carcinomas of the Breast: A Report of Three New Cases ...
Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. J Am Acad Dermatol. 2018 Feb;78(2):249-261. ... Indications for preoperative imaging for high-risk cutaneous squamous cell carcinoma of the head and neck. By William R. Ryan, ... Management of High-Risk Squamous Cell Carcinoma of the Skin. Curr Treat Options Oncol. 2016 Jul;17(7):34. doi: 10.1007/s11864- ... Navarrete-Dechent C, Veness MJ, Droppelmann N, Uribe P. High-risk cutaneous squamous cell carcinoma and the emerging role of ...
Cervical Cancer e-Tumor Boards: Case 1: Cervical Adenosquamous Carcinoma. e-Tumor Boards September 8, 2023 ...
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer ... Another factor potentially affecting incidence trends is the increase in rates of adenocarcinomas and adenosquamous carcinomas ... Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its ... Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of ...
Low-grade adenosquamous carcinoma (a type of metaplastic carcinoma). This rare tumor is usually slow-growing and often mistaken ... Medullary Carcinoma of the Breast," "IDC Type: Mucinous Carcinoma of the Breast," "IDC Type: Papillary Carcinoma of the Breast ... Clinical Cancer Investigation Journal: "Low-grade adenosquamous carcinoma of the breast: A case report and review of literature ... International Journal of Surgery: "Low-grade adenosquamous carcinoma of the breast: A diagnostic and clinical challenge." ...
Cellular organization and histogenesis of adenosquamous carcinoma of the pancreas: evidence supporting the squamous metaplasia ... carcinoma J. O. Rasmussen, S. L. von Holstein, J. U. Prause, B. Vainer, A. B. Hansen, Andre Fehr, Göran Stenman, S. Heegaard ... Carcinoma J. P. North, T. H. McCalmont, Andre Fehr, A. van Zante, Göran Stenman, P. E. LeBoit American Journal of Surgical ... Carcinomas Andre Fehr, J. Bullerdiek, T. Jaekel , T. Löning In: Salivary Gland Cancer. 1 ed. Licitra L, Locati L, editors. - ...
  • Carcinoma of cervix is classified as per the WHO classification into primary tumors which are predominantly epithelial tumors, mesenchymal tumors and tumor like lesions, mixed epithelial stromal tumors, melanocytic, germ cell, and lymphoid tumors. (cytojournal.com)
  • Carcinoma cervix is not the only cancer caused by HPV. (cytojournal.com)
  • ients with recurrent unresectable or metastatic cervix carcinoma with squamous cell, adenocarcinoma or adenosquamous histology immediately after at the very least on prior platinum-based chemotherapy for metastatic/recurrent illness.Coquan et al. (trpv1inhibitor.com)
  • BMC Cancer(2021) 21:Page 5 ofTable 1 Study eligibility criteriaInclusion criteria - Female 18 years of age or older, with histologically confirmed recurrent unresectable or metastatic cervix carcinoma with squamous cell, adenocarcinoma or adenosquamous histology. (trpv1inhibitor.com)
  • Thirty-eight patients with surgically treated stage IB adenosquamous carcinoma of the uterine cervix (AS) have been matched with patients with other histologic subtypes of adenocarcinoma (A) for stage, lesion size, node status, grade of adenocarcinoma and age at diagnosis. (bmj.com)
  • We report a case of simultaneous Squamous cell carcinoma(SCC) of cervix and fallopian tube (invasive). (amrita.edu)
  • Women with primary untreated invasive squamous-cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix of stage IIB, III, or IVA, without involvement of the para-aortic lymph nodes, were enrolled. (nih.gov)
  • Background: Adenosquamous carcinoma of the pancreas is rare. (utmb.edu)
  • Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database (1988 to 2007), we identified patients with adenosquamous carcinoma (n = 415) or adenocarcinoma (n = 45,693) of the pancreas. (utmb.edu)
  • Conclusions: This is the first population-based study to evaluate outcomes in adenosquamous carcinoma of the pancreas. (utmb.edu)
  • Low-grade adenosquamous carcinoma (a type of metaplastic carcinoma). (webmd.com)
  • Ductal carcinoma in situ (DCIS) is noninvasive breast cancer that is limited to the inside of the ducts of the breast. (medscape.com)
  • Lobular carcinoma in situ (LCIS) is noninvasive breast cancer that arises from the lobule at the terminal end of the duct and shows a rather diffuse distribution throughout the breast, which explains its presentation as a nonpalpable mass in most cases (see the images below). (medscape.com)
  • In addition of the categories of squamous dysplasia and carcinoma in situ , two additional lesions were added to the group of pre-invasive lesions: atypical adenomatous hyperplasia (AAH) and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). (ersjournals.com)
  • Increased use of screening mammography has resulted in a dramatic increase in the detection of ductal carcinoma in situ (DCIS). (medscape.com)
  • Large cell neuroendocrine carcinoma (LCNEC) is now recognized as a histologically high grade non small cell carcinoma showing histopathological features of neuroendocrine differentiation as well as immunohistochemical neuroendocrine markers. (ersjournals.com)
  • Though the majority of the primary tumors are hepatocellular carcinoma (HCC), some rare diseases also could not be ignored by the reason of their characteristics. (biomedcentral.com)
  • Squamous cell carcinoma (SCC) in various morphological forms needs to be separated from other epithelial tumors for treatment modality selection. (cytojournal.com)
  • Breast cancer usually begins either in your glands that make milk (called lobular carcinoma ) or the ducts that carry it to the nipple (called ductal carcinoma ). (webmd.com)
  • This is ductal carcinoma in its earliest stage (stage 0). (webmd.com)
  • This is also called epidermoid carcinoma. (doereport.com)
  • A mixed adenocarcinoma and squamous cell or epidermoid carcinoma. (bvsalud.org)
  • As compared to the previous edition, changes include a better definition of pre-invasive lesion, a reclassification of adenocarcinoma, the description of two new tumour types as variants of large cell carcinoma, large cell neuroendocrine carcinoma (LCNEC) and basaloid carcinoma, and a new class called pleomorphic carcinoma. (ersjournals.com)
  • Primary hepatic ASC was defined as a liver tumor containing definite components of both adenocarcinoma and squamous cell carcinoma, and sometimes it was considered as a variant of cholangiocarcinoma [ 9 ]. (biomedcentral.com)
  • ASC has also been identified in the esophagus, anus, and vagina, where squamous cell carcinomas predominate. (biomedcentral.com)
  • WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. (who.int)
  • Women with low-grade DCIS are at higher risk of developing invasive breast cancer than women without DCIS, but are less likely to have a recurrence of the breast carcinoma or to develop new cancers than women with higher-grade DCIS. (medscape.com)
  • 2 Diagnosis of small cell (neuroendocrine) or mucinous adenocarcinoma of cervical cancer (ie, mucinous NOS, intestinal type, signet ring cell type, invasive stratified mucin producing carcinoma and gastric type) based on 2020 WHO classification of cervical cancer. (who.int)
  • Although some published studies have analyzed and discussed adenosquamous carcinomas, hybrid malignancy of the ampulla of Vater has rarely been discussed thus far in the literature. (biomedcentral.com)
  • Adenosquamous carcinoma of the oral cavitiy: a rare epithelial malignancy. (creighton.edu)
  • Adenosquamous carcinoma is defined as a tumor in which both glandular and squamous elements are histologically malignant. (biomedcentral.com)
  • Adenosquamous carcinoma is a type of cancer that contains two types of cells: squamous cells (thin, flat cells that line certain organs) and gland-like cells. (wikipedia.org)
  • Adenosquamous carcinoma entry in the public domain NCI Dictionary of Cancer Terms This article incorporates public domain material from Dictionary of Cancer Terms. (wikipedia.org)
  • Patients were diagnosed with cervical cancer FIGO stage IIB to IVA with a histopathology of squamous cell carcinoma, adenosquamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma. (cochrane.org)
  • Squamous cell carcinoma: Cancer that begins in squamous cells, which are thin, flat cells that look like fish scales. (doereport.com)
  • Large cell carcinoma: Cancer in which the cells are large and look abnormal when viewed under a microscope. (doereport.com)
  • Adenosquamous carcinoma: Cancer that begins in cells that look flattened when viewed under a microscope. (doereport.com)
  • Undifferentiated carcinoma: Cancer cells that do not look like normal cells and multiply uncontrollably. (doereport.com)
  • Between February 2009 and July 2013, 402 patients with clinical stage I non-small cell lung cancer (NSCLC) underwent "non-grasping en bloc MLND" conducted by one surgical team. (medscape.com)
  • Primary carcinoma of the fallopian tube is a rare neoplasm, accounting for only 0.3-1.1% of all gynecological malignancies [1]. (amrita.edu)
  • Additionally, surgical samples from seven patients diagnosed with EGFR -mutant primary lung squamous carcinoma (LUSC) were collected. (springernature.com)
  • Primary Intrahepatic Adenosquamous Carcinoma (iASC) is a very rare subtype of Cholangiocarcinoma (CCA), with a worse prognosis than adenocarcinoma. (oncologyradiotherapy.com)
  • Adenosquamous carcinoma of the ampulla of Vater is a rare disease with a dismal prognosis. (biomedcentral.com)
  • Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect? (nih.gov)
  • The large cell carcinoma class has been enriched with several variants, including the LCNEC and the basaloid carcinoma, both with a dismal prognosis. (ersjournals.com)
  • Meanwhile, 40 hepatocellular carcinoma (HCC) patients and 26 metastatic hepatic SCC or ASC patients who were hospitalized in the same period were also reviewed to make a comparison. (biomedcentral.com)
  • OBJECTIVES: I. Evaluate the efficacy of paclitaxel and carboplatin with amifostine on progression free survival and overall survival in patients with metastatic or recurrent epithelial endometrial carcinoma not amenable to surgery or radiotherapy. (knowcancer.com)
  • Finally, a new class was defined called carcinoma with pleomorphic, sarcomatoid, or sarcomatous elements, which brings together a number of proliferations characterized by a spectrum of epithelial to mesenchymal differentiation. (ersjournals.com)
  • Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression. (nih.gov)
  • Compared with pancreatic adenocarcinoma, adenosquamous carcinoma was more likely to occur in the pancreatic tail, be poorly differentiated, larger, and node positive. (utmb.edu)
  • Sarcomas and basal cell carcinomas with underlying adenocarcinoma also occur. (msdmanuals.com)
  • We reviewed the clinical features and outcomes of three primary hepatic squamous cell carcinoma (SCC) patients and six primary hepatic adenosquamous carcinoma (ASC) patients from January 1998 to December 2011 in Eastern Hepatobiliary Surgery Hospital in China. (biomedcentral.com)
  • Esophageal Primary Intrahepatic Adenosquamous Carcinoma (IASC) is defined by the coexistence of both squamous and glandular elements in the same lesion histologically. (oncologyradiotherapy.com)
  • Similarly, under Carcinoma, specific renamed or deleted in later revisions of tumour classifications. (who.int)
  • This study sought to investigate the efficacy and safety of a three-drug combination antiemetic regimen of olanzapine combined with aprepitant and palonosetron for the prevention of chemoradiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma. (centerwatch.com)
  • Preoperative imaging for high-risk cutaneous squamous cell carcinoma (HRcSCC) of the head and neck lacks robust diagnosis-specific data regarding utility and lacks established guidelines regarding indications. (ahns.info)
  • Resection was the strongest independent predictor of survival for patients with locoregional pancreatic adenosquamous carcinoma (HR 2.35, 95% CI = 1.47-3.76). (utmb.edu)
  • however, patients with adenosquamous carcinoma can still benefit from surgical resection, which is the strongest predictor of survival. (utmb.edu)
  • Another change is the subclassification of adenocarcinoma: the definition of bronchioalveolar carcinoma has been restricted to noninvasive tumours. (ersjournals.com)
  • Adeno-carcinoma is the predominant type and is included in the criteria established by Finn and Javert for diagnosis of primary carcinoma of fallopian tube [2]. (amrita.edu)
  • Upon reviewing the medical records of our institute, we identified 4 patients who were diagnosed with adenosquamous carcinoma of the ampulla of Vater in the past 2 decades. (biomedcentral.com)
  • We determined that miR-375-3p can discriminate between SCLC and NSCLC patients, and between SCLC and Squamous Cell Carcinoma patients. (frontiersin.org)